Company context

Eli Lilly and Company

NYSE:LLY

Pharmaceuticals: Major · benchmarked against Pharmaceuticals: Major inside the VWRA constituent company universe.

Active tabPeers

Current readMixed

Last close1,166.59

1M return-2.79%

OverviewVerdict, thesis map, and valuation setup.FundamentalsDrivers, trajectory, and business quality.Financial reportsStatement tables, sorting, filtering, and acceleration.Ex-ante forecastTarget price, dividend yield, and total return by horizon.FactorsCompany factor exposure, rank, and universe context.Market viewMomentum, catalysts, charts, and symbol packet.AttributionLarge-move causes, residuals, and research backlog.OwnershipSEC 13F holder flow, crowding, and manager changes.PeersPeer heatmap and closest comparables.

Tab scope

Relative comparables

Peers

Source and lookbackPeer fundamentals and stored return summaries5100 stored daily bars; peer return rows use each peer's stored price summary where available.

Sample and caveat12 closest comparables from industry, sector, and market peer pools.Use this tab for its stated job; heavier model packets stay on their own tabs.

Peer return matrix

Cumulative returns across peer horizons

Stored daily closes, when available

NYSE:LLY 1W -0.22%, 1M -2.79%, 3M +18.07%, 6M +15.76%, 1Y +59.24%, 3Y +110.71%; NYSE:JNJ 1W -0.08%, 1M -3.69%, 3M +9.10%, 6M +1.22%, 1Y +40.97%, 3Y +50.23%; NYSE:MRK 1W -1.47%, 1M -0.81%, 3M +11.72%, 6M +4.94%, 1Y +49.49%, 3Y +14.10%; SIX:NOVN 1W +2.00%, 1M +0.50%, 3M +8.47%, 6M +4.59%, 1Y +35.11%, 3Y +38.52%; OMXCOP:NOVO_B 1W -3.22%, 1M +1.21%, 3M +11.95%, 6M +15.80%, 1Y +12.26%, 3Y -40.92%; SIX:ROP 1W -0.57%, 1M -0.63%, 3M +3.22%, 6M -7.49%, 1Y +32.62%, 3Y +21.84%; NASDAQ:VRTX 1W -0.84%, 1M -9.00%, 3M +10.39%, 6M +1.62%, 1Y +23.25%, 3Y +37.67%; LSE:AZN 1W -1.44%, 1M -11.73%, 3M -9.59%, 6M -12.13%, 1Y +12.27%, 3Y +14.44%; NYSE:ABBV 1W +0.33%, 1M +0.18%, 3M +21.88%, 6M +9.13%, 1Y +21.30%, 3Y +73.99%; NYSE:PFE 1W -0.89%, 1M +5.04%, 3M -1.64%, 6M -6.26%, 1Y +0.63%, 3Y -31.51%; EURONEXT:UCB 1W +1.01%, 1M -5.62%, 3M +0.42%, 6M -9.40%, 1Y +26.17%, 3Y +192.02%

Company1W1M3M

6M

1Y

3Y

NYSE:LLY-0.22%-2.79%+18.07%+15.76%+59.24%+110.71%

NYSE:JNJ-0.08%-3.69%+9.10%+1.22%+40.97%+50.23%

NYSE:MRK-1.47%-0.81%+11.72%+4.94%+49.49%+14.10%

SIX:NOVN+2.00%+0.50%+8.47%+4.59%+35.11%+38.52%

OMXCOP:NOVO_B-3.22%+1.21%+11.95%+15.80%+12.26%-40.92%

SIX:ROP-0.57%-0.63%+3.22%-7.49%+32.62%+21.84%

NASDAQ:VRTX-0.84%-9.00%+10.39%+1.62%+23.25%+37.67%

LSE:AZN-1.44%-11.73%-9.59%-12.13%+12.27%+14.44%

NYSE:ABBV+0.33%+0.18%+21.88%+9.13%+21.30%+73.99%

NYSE:PFE-0.89%+5.04%-1.64%-6.26%+0.63%-31.51%

EURONEXT:UCB+1.01%-5.62%+0.42%-9.40%+26.17%+192.02%

Peer scorecard analytics

Different ways to compare this peer set

11 companies including target

Return leadership

NYSE:LLY+59.24% 1Y · +110.71% 3Y

NYSE:MRK+49.49% 1Y · +14.10% 3Y

NYSE:JNJ+40.97% 1Y · +50.23% 3Y

SIX:NOVN+35.11% 1Y · +38.52% 3Y

Risk and quality spread

NYSE:LLYGM +82.83% · ROE +107.64%

OMXCOP:NOVO_BGM +81.85% · ROE +71.40%

NYSE:JNJGM +75.08% · ROE n/a

NYSE:ABBVGM +70.58% · ROE n/a

Valuation screen

OMXCOP:NOVO_BP/E 11.96 · FCF yield +2.74%

NYSE:PFEP/E 18.98 · FCF yield +6.72%

SIX:ROPP/E 20.57 · FCF yield +5.40%

SIX:NOVNP/E 21.93 · FCF yield +6.29%

Valuation versus growth

P/E against 1Y return

NYSE:LLY P/E 41.28 1Y +59.24%, NYSE:JNJ P/E 28.84 1Y +40.97%, NYSE:MRK P/E 35.01 1Y +49.49%, SIX:NOVN P/E 21.93 1Y +35.11%, OMXCOP:NOVO_B P/E 11.96 1Y +12.26%, SIX:ROP P/E 20.57 1Y +32.62%, NASDAQ:VRTX P/E 28.49 1Y +23.25%, LSE:AZN P/E 24.94 1Y +12.27%, NYSE:ABBV P/E 124.97 1Y +21.30%, NYSE:PFE P/E 18.98 1Y +0.63%, EURONEXT:UCB P/E 29.94 1Y +26.17%

Peer heatmap

Where this company wins and lags

12 stored peers

CompanyP/E TTMPrice / SalesFCF yieldGross marginReturn on equityDebt / Equity

NYSE:LLYEli Lilly and Company

41.2817th pctile14.623rd pctile+1.09%7th pctile+82.83%87th pctile+107.64%100th pctile1.3910th pctile

NYSE:JNJJohnson & Johnson

28.8429th pctile6.3029th pctilen/an/a+75.08%57th pctilen/an/an/an/a

NYSE:MRKMerck & Company, Inc.

35.0114th pctile4.8157th pctile+4.59%67th pctile+73.44%14th pctile+18.97%0th pctile1.0733rd pctile

SIX:NOVNNovartis AG

21.9371st pctile5.4143rd pctile+6.29%100th pctile+74.60%43rd pctile+33.54%50th pctile1.2217th pctile

OMXCOP:NOVO_BNovo Nordisk A/S Class B

11.96100th pctile4.5671st pctile+2.74%17th pctile+81.85%71st pctile+71.40%83rd pctile0.7267th pctile

SIX:ROPRoche Holding Ltd

20.5786th pctile4.33100th pctile+5.40%83rd pctile+73.23%0th pctile+39.29%67th pctile0.9850th pctile

NASDAQ:VRTXVertex Pharmaceuticals Incorporated

28.4943rd pctile10.0914th pctile+3.04%33rd pctile+86.38%100th pctile+24.20%33rd pctile0.10100th pctile

LSE:AZNAstraZeneca PLC

24.9457th pctile4.3786th pctile+4.33%50th pctile+74.31%29th pctile+22.89%17th pctile0.7283rd pctile

Color ranks each metric in the favorable direction, so lower leverage and cheaper multiples can still score green.